Tianda Pharmaceuticals Ltd. ( (HK:0455) ) has provided an announcement.
Tianda Pharmaceuticals Ltd. has issued a profit warning, indicating an expected increase in losses for the financial year ending December 31, 2024. The anticipated loss of not less than HK$61 million is attributed to a 38% decrease in revenue and a non-recurring impairment of goodwill amounting to HK$1.3 million. This announcement highlights challenges in the company’s financial performance, which may impact its market positioning and investor confidence.
More about Tianda Pharmaceuticals Ltd.
Tianda Pharmaceuticals Ltd., incorporated in the Cayman Islands, operates in the pharmaceutical industry. The company, along with its subsidiaries, focuses on the development and sale of pharmaceutical products.
YTD Price Performance: -1.18%
Average Trading Volume: 75,260
Technical Sentiment Signal: Buy
Current Market Cap: HK$387M
Learn more about 0455 stock on TipRanks’ Stock Analysis page.